CDH2 and cancer: The up-regulation of P-cadherin and N-cadherin can trigger the activation of signaling pathways associated with cancer cell growth, migration, and invasion, including receptor tyrosine kinase, PI3K/AKT, Rho GTPases, and Hippo pathways [71,72].